Rite Aid Corporation
RAD
OTC PK
| Weiss Ratings | RAD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | RAD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | RAD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.98 | |||
| Price History | RAD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -83.33% | |||
| 2-Year Total Return | -99.72% | |||
| 3-Year Total Return | -99.89% | |||
| 5-Year Total Return | -99.93% | |||
| 52-Week High % Change | -97.50% | |||
| 52-Week Low % Change | 9,900.00% | |||
| Price | RAD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.40 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 12, 2024 | |||
| 52-Week High Price (Date) | Mar 13, 2024 | |||
| Valuation | RAD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -29.61 | |||
| Earnings Per Share Growth | 91.15% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 0.28 | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | 32.57 | |||
| Enterprise Value/EBIT | -87.91 | |||
| Market Cap Category | -- | |||
| Dividends and Shares | RAD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 55.31M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | RAD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | -- | |||
| Website | www.riteaid.com | |||
| Country | United States | |||
| Year Founded | 1962 | |||
| Profitability | RAD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -0.31% | |||
| Profit Margin | -6.96% | |||
| Management Effectiveness | RAD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.60% | |||
| Return on Equity | -- | |||
| Income Statement | RAD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 23.48B | |||
| Total Revenue (TTM) | 23.48B | |||
| Revenue Per Share | $424.47 | |||
| Gross Profit (TTM) | 4.73B | |||
| EBITDA (TTM) | 199.11M | |||
| EBIT (TTM) | -73.77M | |||
| Net Income (TTM) | -1.63B | |||
| Net Income Avl. to Common (TTM) | -1.63B | |||
| Total Revenue Growth (Q YOY) | -4.32% | |||
| Earnings Growth (Q YOY) | -207.90% | |||
| EPS Diluted (TTM) | -29.61 | |||
| EPS Diluted Growth (Q YOY) | -203.68% | |||
| Balance Sheet | RAD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 97.12M | |||
| Cash Per Share (Q) | $1.76 | |||
| Total Current Assets (Q) | 3.74B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -1.97B | |||
| Current Ratio (Q) | 0.574 | |||
| Book Value Per Share (Q) | -$35.48 | |||
| Total Assets (Q) | 7.13B | |||
| Total Current Liabilities (Q) | 6.52B | |||
| Total Debt (Q) | 6.58B | |||
| Total Liabilities (Q) | 9.09B | |||
| Total Common Equity (Q) | -1.97B | |||
| Cash Flow | RAD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -111.66M | |||
| Cash from Financing (TTM) | 571.91M | |||
| Net Change in Cash (TTM) | 46.12M | |||
| Levered Free Cash Flow (TTM) | -14.80M | |||
| Cash from Operations (TTM) | -414.14M | |||
